Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that affects the spinal joints and the joints that connect the bottom of the spine to the hip bones (the sacroiliac joints). Experts ...

Atul A. Deodhar, MD: Axial spondyloarthritis is an umbrella term that includes nonradiographic axial spondyloarthritis and ankylosing spondylitis. There is a lot of confusion about this term. In ...

Atul A. Deodhar, MD: The use of opioids is quite common in this population, mainly because back pain is so common in this population. Depending on which survey you look at, 30% to 40% of the patients ...

Please provide your email address to receive an email when new articles are posted on . Acute anterior uveitis in first-degree relatives of axial spondyloarthritis ...

Patients with axSpA can wait 10 years after symptom onset to be diagnosed with the condition. There are currently no guidelines to advise clinicians on when to refer to a rheumatologist, and with the ...

Please provide your email address to receive an email when new articles are posted on . Among patients diagnosed with definite axial SpA at baseline, 94% retained the diagnosis 2 years later. Features ...

Outpatient data show 13.90% radiographic hip involvement in axial spondyloarthritis, linked to longer duration and higher disease severity.

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically ...

a Since enthesitis, dactylitis, uveitis, peripheral arthritis, psoriasis and IBD might not be present at disease onset but might develop later, it is recommended to ignore a negative result for these ...

MoonLake Immunotherapeutics recently reported full-year 2025 results showing a wider net loss of US$227.32 million and a basic loss per share of US$3.53, alongside announcing positive topline Phase 2 ...

Patients with axial psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) plus psoriasis differ with respect to clinical and genetic characteristics, according to the findings of a recent ...

Adding methotrexate to adalimumab (Humira) in axial spondyloarthritis was associated with reduced immunogenicity, as shown by a lower rate of developing antidrug antibodies, French researchers ...